Suppr超能文献

接受局限性前列腺癌根治性前列腺切除术的年轻男性的长期肿瘤学结局

Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer.

作者信息

Milonas Daimantas, Venclovas Zilvinas, Gudinaviciene Inga, Zviniene Kristina, Matjosaitis Aivaras Jonas

机构信息

Department of Urology, Lithuanian University of Health Sciences, Medical Academy, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania.

Department of Pathology, Lithuanian University of Health Sciences, Medical Academy, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania.

出版信息

Biomed Res Int. 2017;2017:9858923. doi: 10.1155/2017/9858923. Epub 2017 Feb 19.

Abstract

. The aim of this study was to describe PCa characteristics and long-term outcomes in young men aged ≤55 years after radical prostatectomy (RP) and to compare them with older men cohort. . Among 2,200 patients who underwent RP for clinically localized PCa at our centre between 2001 and 2015, 277 (10.3%) men aged ≤55 years were identified. All preoperative and pathological parameters were compared between groups. Biochemical progression free survival (BPFS) and disease progression free survival (DPFS) were assessed at 5 and 10 years. . Men aged ≤55 years had similar pathological tumor characteristics and biochemical recurrence rate (BCR) compared to their older counterparts. Disease progression rate 2.5% versus 0.4% was higher in older patients ( = 0.026). BPFS rate was not different in both study groups. Estimated 10-year DPFS was 98.8% in younger men compared to 89.2% in their older counterparts ( = 0.031). Multivariate Cox regression showed that Gleason score lymph-nodes and surgical margins status were significant predictors for disease progression. . In our cohort, men aged ≤55 years had similar pathological PCa characteristics and BCR rate in comparison with older men. RP can be performed with excellent long-term DPFS results in men with localized PCa at ≤55 years of age.

摘要

本研究的目的是描述年龄≤55岁的年轻男性在根治性前列腺切除术(RP)后的前列腺癌特征和长期预后,并将其与老年男性队列进行比较。在2001年至2015年间于我们中心接受临床局限性前列腺癌RP治疗的2200例患者中,确定了277例(10.3%)年龄≤55岁的男性。对两组之间的所有术前和病理参数进行了比较。在5年和10年时评估了无生化进展生存期(BPFS)和无疾病进展生存期(DPFS)。年龄≤55岁的男性与老年男性相比,具有相似的病理肿瘤特征和生化复发率(BCR)。老年患者的疾病进展率为2.5%,而老年患者为0.4%(P = 0.026)。两个研究组的BPFS率没有差异。年轻男性的估计10年DPFS为98.8%,而老年男性为89.2%(P = 0.031)。多变量Cox回归显示,Gleason评分、淋巴结和手术切缘状态是疾病进展的重要预测因素。在我们的队列中,年龄≤55岁的男性与老年男性相比,具有相似的病理前列腺癌特征和BCR率。对于年龄≤55岁的局限性前列腺癌男性,RP可以取得优异的长期DPFS结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/1f370815e6b7/BMRI2017-9858923.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验